全文获取类型
收费全文 | 1674篇 |
免费 | 139篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 93篇 |
妇产科学 | 28篇 |
基础医学 | 257篇 |
口腔科学 | 29篇 |
临床医学 | 177篇 |
内科学 | 378篇 |
皮肤病学 | 42篇 |
神经病学 | 84篇 |
特种医学 | 54篇 |
外科学 | 268篇 |
综合类 | 38篇 |
一般理论 | 1篇 |
预防医学 | 109篇 |
眼科学 | 44篇 |
药学 | 106篇 |
中国医学 | 4篇 |
肿瘤学 | 100篇 |
出版年
2023年 | 8篇 |
2022年 | 26篇 |
2021年 | 53篇 |
2020年 | 35篇 |
2019年 | 55篇 |
2018年 | 56篇 |
2017年 | 35篇 |
2016年 | 37篇 |
2015年 | 48篇 |
2014年 | 71篇 |
2013年 | 79篇 |
2012年 | 114篇 |
2011年 | 99篇 |
2010年 | 59篇 |
2009年 | 63篇 |
2008年 | 85篇 |
2007年 | 88篇 |
2006年 | 98篇 |
2005年 | 63篇 |
2004年 | 59篇 |
2003年 | 50篇 |
2002年 | 28篇 |
2001年 | 36篇 |
2000年 | 43篇 |
1999年 | 24篇 |
1998年 | 21篇 |
1997年 | 14篇 |
1996年 | 22篇 |
1995年 | 22篇 |
1994年 | 11篇 |
1992年 | 38篇 |
1991年 | 23篇 |
1990年 | 25篇 |
1989年 | 27篇 |
1988年 | 21篇 |
1987年 | 19篇 |
1986年 | 18篇 |
1985年 | 15篇 |
1984年 | 11篇 |
1983年 | 8篇 |
1982年 | 7篇 |
1980年 | 6篇 |
1979年 | 10篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1973年 | 8篇 |
1970年 | 7篇 |
排序方式: 共有1816条查询结果,搜索用时 15 毫秒
991.
Sankaranarayanan R Swaminathan R Jayant K Brenner H 《IARC scientific publications》2011,(162):257-291
Population-based cancer survival data, a key indicator for monitoring progress against cancer, are reported from 27 population-based cancer registries in 14 countries in Africa, Asia, the Caribbean and Central America. In China, Singapore, the Republic of Korea, and Turkey, the 5-year age-standardized relative survival ranged from 76-82% for breast, 63-79% for cervical, 71-78% for bladder, and 44-60% for large-bowel cancer. Survival did not exceed 22% for any cancer site in The Gambia, or 13% for any cancer site except breast (46%) in Uganda. For localized cancers of the breast, large bowel, larynx, ovary, urinary bladder and for regional diseases at all sites, higher survival rates were observed in countries with more rather than less developed health services. Inter- and intra-country variations in survival imply that the levels of development of health services and their efficiency to provide early diagnosis, treatment and clinical follow-up care have a profound impact on survival from cancer. These are reliable baseline summary estimates to evaluate improvements in cancer control and emphasise the need for urgent investment to improve awareness, population-based cancer registration, early detection programmes, health-services infrastructure, and human resources in these countries in the future. 相似文献
992.
Irene M. Ghobrial Wanling Xie Swaminathan Padmanabhan Ashraf Badros Meghan Rourke Renee Leduc Stacey Chuma Janet Kunsman Diane Warren Tiffany Poon Brianna Harris Amy Sam Kenneth C. Anderson Paul G. Richardson Steven P. Treon Edie Weller Jeffrey Matous 《American journal of hematology》2010,85(9):670-674
993.
994.
995.
996.
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence 下载免费PDF全文
Battiwalla M Hahn T Radovic M Roy H Wahab A Duman E Bajwa R Padmanabhan S Becker J Barrett AJ McCarthy PL 《Blood》2006,107(5):1970-1973
The DR15 allele at the HLA DRB1 locus is a marker for immune-mediated bone marrow failure syndromes. We hypothesized that HLA DR15 plays a role in T-cell interactions with hematopoiesis and investigated the role of HLA DR15 on graft-versus-host disease (GVHD) and graft-versus-leukemia effects in HLA-matched allogeneic blood or marrow transplantation (BMT) performed for myeloid malignancies. We performed a retrospective analysis of 119 consecutive related and 48 consecutive unrelated allogeneic BMT for myeloid malignancies treated between 1991 and 2005 to investigate the influence of HLA DR15 on overall survival (OS), progression-free survival (PFS), and incidence of grades II to IV acute GVHD. HLA DR15 was determined by either molecular (n = 108) or serologic (n = 59) methods. The incidence of HLA DR15 was similar to the general white population (35/167 = 21%). There were no significant differences in transplantation characteristics between the HLA DR15-positive and -negative groups. There was no significant difference in chronic GVHD, OS, or PFS between the HLA DR15-positive versus-negative groups in any disease or donor relation subgroups. The HLA DR15-positive group experienced a significantly lower incidence of acute GVHD grades II to IV: 23% versus 42% (P = .041). These results suggest that HLA DR15 reduces the risk of acute GVHD. 相似文献
997.
Changes in peripheral nerve stress relaxation after transection were measured weekly for 5 weeks in the distal stumps of sciatic nerves of 50 Sprague-Dawley rats. Each week after transection the distal stumps of the transected nerves showed decreased stress relaxation compared with the freshly transected contralateral nerves after undergoing a 10% elongation. The transected side always showed less stress relaxation at 30 minutes than the intact contralateral side (average, 24%; range, 15% to 32%). A statistically significant difference in mean stress relaxation between the cut nerves and the uncut sciatic nerves occurred for weeks 1 through 4. Week 5 demonstrated a decrease in mean stress relaxation of the experimental side compared with the contralateral control side but this was not statistically significant. Decreased stress relaxation of the distal stump results in increased tension at the suture line as the nerve gap is overcome when performing a delayed neurorrhaphy at 1 to 5 weeks after transection. 相似文献
998.
Anandarao R Swaminathan S Fernando S Jana AM Khanna N 《Clinical and Vaccine Immunology : CVI》2006,13(1):59-67
Dengue fever is a mosquito-borne viral disease prevalent mainly in tropical countries. As the clinical manifestations of dengue are not very unique, laboratory diagnosis is crucial in identifying cases of dengue infection. Detection of dengue infection based on the identification of antidengue antibodies has emerged as a practical and reliable means of diagnosing dengue fever. We recently developed a customized recombinant dengue multiepitope protein (r-DME-G) that can specifically detect the immunoglobulin G (IgG) class of antidengue antibodies in patient sera. Using this strategy, we have now created another dengue multiepitope protein, r-DME-M, with specificity for the IgM class of antidengue antibodies. A synthetic gene encoding the r-DME-M protein was expressed as a maltose-binding protein fusion in Escherichia coli. The recombinant protein was purified in a single affinity chromatographic step to obtain yields of approximately 15 mg purified protein/liter of culture. The purified protein was used to develop an in-house IgM enzyme-linked immunosorbent assay (ELISA) and tested using a panel of 172 patient sera characterized using the commercially available Dengue Duo rapid strip test from PanBio, Australia. The IgM ELISA results showed that the r-DME-M protein not only recognized all IgM(+) samples identified by the PanBio test but also identified samples missed by the latter test. We also successfully adapted the r-DME-M protein to a rapid strip test format. This approach of creating customized antigens coupled to overexpression in E. coli and simple purification offers a promising alternative option to dengue diagnosis with the potential to circumvent the drawbacks of the whole virus antigen-based commercial kits. 相似文献
999.
1000.
K Rivet Amico Catalina Ramirez Margaret R Caplan Brooke EE Montgomery Jennifer Stewart Sally Hodder Shobha Swaminathan Jing Wang Noshima Y Darden‐Tabb Marybeth McCauley Kenneth H Mayer Timothy Wilkin Raphael J Landovitz Roy Gulick Adaora A Adimora 《Journal of the International AIDS Society》2019,22(3)